Released juvenile animal research demonstrate that the administration of anesthetic and sedation drugs, including Pentobarbital Sodium Injection USP, (Nembutal) that either block NMDA receptors or potentiate the exercise of GABA in the duration of rapid Mind development or synaptogenesis, ends in widespread neuronal and oligodendrocyte mobile loss